Swedish Orphan Biovitrum AB's total assets for Q4 2024 were kr75.44B, an increase of 4.50% from the previous quarter. GB:0MTD total liabilities were kr35.15B for the fiscal quarter, a 0.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.